This lncRNA increased the cell growth, survival, migration, invasion and tumour formation of ovarian cancer cells by inhibiting miR‐455‐5p and miR‐491‐5p, thus liberating the expression of E2F2 cancer‐promoting gene (Figure 6), which may become a potential molecular marker for ovarian cancer treatment. The gene discussed is E2F2; the disease is neoplasm.